Sarah Collins

Sarah Collins is an accomplished scientist with extensive experience in chemical biology and oncology. Currently serving as a Principal Scientist at Orbit Discovery since December 2018, Sarah has held multiple roles including Senior Scientist and Scientist. Prior experience includes a DPhil in Chemical Biology from the University of Oxford, where significant contributions involved developing hypoxia-activated prodrug strategies and conducting advanced research presentations. Early in the career, Sarah gained insights into pharmacovigilance during a work experience at PharSafer Associates Ltd. Educational background includes a MSci in Natural Sciences from Durham University, complemented by a strong foundation from Zurich International School.